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Introduction 
Poor cardiac function can affect the kidney 
through several mechanisms [1]. Acute kidney 
injury (AKI) is common after coronary artery 
bypass grafting (CABG), especially when 
cardiopulmonary bypass (CPB) is used [2]. 
Preoperative coronary angiography may cause 
contrast-induced nephropathy and affect the 
renal function further in coronary artery 
disease patients [3]. 
Acute kidney injury (AKI) increases morbidity 
and mortality after CABG. The incidence of AKI 
varies among studies, which could be attributed to 
the different AKI definitions. Current guidelines for 
AKI diagnosis recommend the use of Kidney 
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Abstract 
Background: Acute kidney injury is a serious complication after coronary artery 
bypass grafting (CABG). This work aimed to assess the impact of the timing of 
coronary angiography on kidney function after on-pump coronary artery bypass 
grafting.
Methods: We included 60 patients who underwent elective isolated on-pump 
coronary artery bypass grafting from 2017 to 2018 at the National Heart Institute 
and Benha University Hospital. We divided the patients into two groups; group І 
included 30 patients with coronary angiography performed less than seven days 
prior to CABG, and Group ІІ included 30 patients who had coronary angiography 
more than seven days prior to CABG. Postoperative acute kidney injury was 
defined according to the consensus kidney disease: Improving Global Outcomes 
Definition and Staging criteria.
Results: The mean body mass index was significantly higher in group I (35.89
±5.15 Kg/ m² vs. 31.72±4.99 Kg/ m², P = 0.002). The mean preoperative 
hemoglobin was higher in group II (12.7 ± 1.5 g/dl vs. 13.9 ± 1.5 g/dl, P = 0.004). 
The frequency of acute kidney damage was higher in patients who had coronary 
angiography less than seven days before CABG but did not reach a significant 
level (46.7 % vs. 30%, P =0.184). There was no difference in the creatinine 
postoperatively between both groups (1.2 ±0.5 vs. 1 ±0.3 mg/dl; p= 0.214).
Conclusions: We found no association between the timing of coronary 
angiography before on-pump coronary artery bypass graft surgery and 
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Disease Improving Global Outcomes (KDIGO) 
criteria, which are based on an exhaustive 
evidence-based review of the literature [4]. The 
aim of this work was to assess the impact of the 
timing of coronary angiography on kidney function 
after on-pump coronary artery bypass grafting. 
Patients and Methods: 
Study subjects: 
This prospective cohort study included 60 
patients with ischemic heart disease who 
underwent elective isolated on-pump coronary 
artery bypass grafting from 2017 to 2018 at the 
National Heart Institute and Benha University 
Hospital. The study protocol was approved by the 
Ethical Committee of Benha Faculty of Medicine. 
Written informed consent was obtained from the 
patients prior to enrollment. The patients were 
divided into 2 groups; Group І included 30 patients 
with coronary angiography performed less than 7 
days before CABG, and Group ІІ included 30 
patients who had coronary angiography more 
than 7 days before CABG. We used 7 days as a 
cutoff according to statistical analysis of Kim and 
associates and a previous report suggesting that 
after exposure to contrast, renal function usually 
comes back to prior levels within 7 to 21 days [3, 
5, 6].  
Patient with poor cardiac function (ejection 
fraction < 30%), serum creatinine > 1.3 mg/dL, and 
those who had re-operative or concomitant 
operations and uncontrolled diabetes mellitus 
were excluded. The baseline laboratory values 
were recorded the day preceding surgery or just 
prior to surgery when coronary angiography was 
performed on the same day of the operation. 
Preoperative, operative and postoperative data 
were prospectively collected and entered into a 
computerized database. 
Data collection: 
Preoperative data included patients’ 
demographics, laboratory data (serum creatinine, 
and estimated glomerular filtration rate (eGFR) 
calculated using the Modification of Diet in Renal 
Disease (MDRD) study equation), 
echocardiographic findings and cardiac 
catheterization data. 
Operative data included total CPB and cross-
clamp times, intraoperative bleeding, 
arrhythmias, and urine output. 
Postoperative data included serum creatinine 
levels, urine output, inotropic support, 
intraoperative balloon pump (IABP), blood 
transfusion, and complications (bleeding, 
reopening, chest Infection, wound infection, 
arrhythmia, reintubation, and renal dialysis), in-
hospital mortality and intensive care unit (ICU) 
and hospital stay period.
Table 1: Demographic data. (Continuous variables are presented as mean and standard deviation and categorical 
variables as number and percent) 
Group I (n = 30)  Group II (n = 30) P-value 
Age (years) 54 ±9 55 ±8 0.736 
Males 24 (80.0 %) 26 (86.7 %) 0.488 
Height (cm) 165 ±5 166 ±5 0.361 
Weight (kg) 98±14 87 ±13 0.005 
BMI (kg/ m²) 35.89±5.15 31.72±4.99 0.002 
Hypertension 20 (66.7 %) 18 (60.0 %) 0.592 
Diabetes mellitus 14 (46.7 %) 12 (40.0 %) 0.602 
Smoking 18 (60.0 %) 17 (56.7 %) 0.793 
Present history of RD 1 (3.3 %) 3 (10.0 %) 0.612 
Past history of RD 0 (0.0) 3 (10.0 %) 0.237 
Medications for RD 0 (0.0) 1 (3.3 %) ˃0.99 
BMI: Body Mass Index; RD: Renal Disease 
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Table 2: Preoperative laboratory data. (Continuous variables are presented as mean and standard deviation and 
categorical variables as number and percent) 
Group I (n = 30) Group II (n = 30) P-value 
HB (g/dl) 12.7 ±1.5 13.9 ±1.5 0.004 
HbA1C (%) 6.1 ±0.8 6 ±0.9 0.765 
Serum creatinine(mg/dl) 1 ±0.3 0.9 ±0.2 0.605 
Serum urea (mg/dl) 38.5 ±18 33.2 ±9.7 0.163 
eGFR (ml/min/1.73m²) 86 ±33 88 ±27 0.792 
Hb: Hemoglobin; HbA1C: Glycated Hemoglobin Test; eGFR: Estimated Glomerular Filtration Rate 
Definitions and endpoint: 
The primary endpoint was the postoperative 
AKI defined according to Kidney Disease: 
Improving Global Outcomes Definition and Staging 
(KDIGO) criteria utilizing the maximal change in 
serum creatinine (sCr) during the initial seven 
postoperative days compared to the preoperative 
values. AKI was defined by one of the following: an 
elevation in sCr 0.3 mg/dL or more within 48 hours 
or an increment in sCr 1.5 times the baseline value 
or more, which was known to have happened 
within the earlier seven days. AKI additionally was 
staged for severity by the following features: Stage 
1, increase in sCr 0.3 mg/dL or more or up to 1.5 
till 1.9 times the baseline value. Stage 2; increase 
in sCr to 2.0 to 2.9 times the baseline value. Stage 
3; rise in sCr 3.0 mg/dL or higher or the initiation 
of renal replacement therapy (RRT) [3-7]. 
Statistical Analysis 
Data management and statistical analysis were 
performed using SPSS vs.25. (IBM, Armonk, New 
York, United States). Numerical data were 
summarized as means and standard deviations. 
Categorical data were summarized as numbers 
and percentages. Comparisons between two 
groups were performed using the independent t-
test. Categorical data were compared using the 
Chi-square test or Fisher's exact test when 
appropriate. P-values less than 0.05 were 
considered significant [8]. 
Results 
Preoperative data: 
The demographic data of the patients are 
shown in Table 1. The mean weight was higher in 
patients who underwent coronary angiography in 
less than seven days before CABG (98 ± 14 Kg vs. 
87 ± 13 Kg, P = 0.005). The mean body mass index 
(BMI) was significantly higher in Group I (35.89 ± 
5.15 Kg/m² vs. 31.72±4.99 Kg/m², P = 0.002). There 
was no difference between groups in other 
variables. 
Table 3: Preoperartive cardiac catheterization data. (Continuous variables are presented as mean and standard 
deviation and categorical variables as number and percent) 
Group I (n = 30) Group II (n = 30) P-value 
LM 11 (36.7 %) 6 (20.0 %) 0.152 
LAD 29 (96.7 %) 30 (100.0 %) ˃0.99 
Diag. 7 (23.3 %) 7 (23.3 %) ˃0.99 
LCX 27 (90.0 %) 21 (70.0 %) 0.053 
OM 12 (40.0 %) 10 (33.3 %) 0.592 
RCA 27 (90.0 %) 22 (73.3 %) 0.095 
PDA 5 (16.7 %) 4 (13.3 %) ˃0.99 
LM: The Left Main Coronary Artery; LAD: Left Anterior Descending branch of LM; Diag.: Diagonal 
branches of LAD; LCX: Left Circumflex branch of LM; OM: Obtuse Marginal branches of LCX; RCA: The 
Right Coronary Artery; PDA: The Posterior Descending Artery 
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Table 4: Urine Output (ml/kg/hr) Intraoperative and postoperative. (Continuous variables are presented as mean and 
standard deviation and categorical variables as number and percent) 
Urine output Group I (n = 30) Group II (n = 30) P-value 
Intraoperative (ml/kg/hr) 7.8 ±3.4 9.4 ±3.9 0.086 
Immediate postoperative (ml/kg/hr) 1.7 ±0.5 1.9 ±0.7 0.076 
At day 1 (ml/kg/hr) 1.6 ±0.5 1.8 ±0.7 0.118 
At day 2 (ml/kg/hr) 1.6 ±0.5 1.5 ±0.5 0.543 
Preoperative laboratory findings of the 
patients are described in Table 2. The mean 
preoperative hemoglobin was higher in those who 
underwent coronary angiography in less than 
seven days before CABG (13.9 ±1.5 g/dl vs. 12.7 
±1.5 g/dl, P = 0.004). The preoperative cardiac 
catheterization findings showed no differences 
between the two groups. (Table 3) 
Operative and postoperative data: 
Urine Output did not differ significantly 
between the two groups. (Table 4) Inotropic 
support, IABP, blood transfusion, and 
postoperative complications showed non-
significant differences between the two groups. 
(Table 5) IABP was inserted post-CABG surgery 
for 2 patients, and during the induction of 
anesthesia in one patient with high-risk CABG 
surgery in group I. Temporary renal dialysis (≤ 3 
times) was reported in one patient in group II. 
Creatinine level, AKI, and KDIGO staging showed 
non-significant differences between the two 
groups. (Table 6 and 7) We did not have 
operative mortality reported in our study. 
Discussion 
In this prospective study of 60 patients who 
underwent elective isolated CABG using CPB, we 
found that the period between coronary 
angiogram and surgery had no effect on 
postoperative AKI. In this study, postoperative AKI 
was defined according to Kidney Disease: 
Improving Global Outcomes Definition and Staging 
(KDIGO) criteria utilizing the maximal change in 
serum creatinine during the initial seven 
postoperative days in comparison to preoperative 
baseline values. 
The 30 patients in Group I who underwent 
surgery after less than seven days of coronary 
angiogram had an increased incidence of 
postoperative AKI (n=14; 46.7%) than those in 
Group II (n=9; 30%). However, AKI and KDIGO 
staging showed non-significant differences 
between the two groups. 
Despite the transient nature of contrast-
induced nephropathy, it may cause persistent 
renal impairment and adverse cardiovascular 
consequences. There are a variety of risk factors 
that may affect the occurrence of contrast-
induced nephropathy, and the prediction of CIN 
remains difficult [9]. Consistent with our study, 
Ko and colleagues found that the time between 
coronary angiogram and cardiac surgery was not a 
risk factor of AKI. AKI happened in 35% of 433 
patients operated within three days of coronary 
Table 5: Comparison of postoperative complications between the groups. (Continuous variables are presented as mean 
and standard deviation and categorical variables as number and percent) 
Group I (n = 30) Group II (n = 30) P-value 
Inotropic Support 26 (86.7 %) 23 (76.7 %) 0.317 
IABP 3 (10.0 %) 0 0.237 
Blood transfusion 26 (86.7 %) 27 (90.0 %) ˃0.99 
Hemorrhage 6 (20.0 %) 4 (13.3 %) 0.488 
Reopening 2 (6.7 %) 4 (13.3 %) 0.671 
Chest infection 0 3 (10.0 %) 0.237 
Wound infection 3 (10.0 %) 1 (3.3 %) 0.301 
Other complications 3 (10.0 %) 4 (13.3 %) ˃0.99 
IABP: Intra-aortic Balloon Pump insertion 
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Table 6: Postoperative serum creatinine levels (mg/dl) during the hospital stay. (Continuous variables are presented as 
mean and standard deviation and categorical variables as number and percent) 
Group I (n = 30) Group II (n = 30) P-value 
Immediate postoperative 1.1 ±0.4 1 ±0.3 0.21 
At day 1 1.2 ±0.5 1 ±0.3 0.214 
At day 2 1.1 ±0.5 1 ±0.4 0.483 
At day 3 1.1 ±0.4 1 ±0.3 0.307 
At day 4 1 ±0.3 1 ±0.4 0.687 
At day 5 1 ±0.3 1 ±0.4 0.843 
At day 6 0.9 ±0.3 1 ±0.4 0.776 
At discharge 0.9 ±0.3 0.9 ±0.2 0.89 
angiogram versus 31% of 1700 patients operated 
after three days. Acute kidney injury was defined 
according to the AKI network and the Risk, Injury, 
Failure, Loss, End-stage (RIFLE) criteria [10]. 
Similarly, Palazouelos and colleagues have shown 
that the timing of coronary angiography did not 
affect the development of postoperative AKI [11]. 
Andersen and coworkers in a study of 285 
consecutive patients, concluded that cardiac 
surgery within 1-3 days of coronary angiography 
was safe and not associated with acute kidney 
injury [12]. 
Table 7: AKI and KDIGO Staging in the study groups. 
(Continuous variables are presented as mean and 
standard deviation and categorical variables as 
number and percent) 
Group I 
(n = 30) 
Group II 
(n = 30) 
P-value 
AKI 14 (46.7 %) 9 (30.0 %) 0.184 
KDIGO 
0 16 (53.3 %) 21 (70.0 %) 
0.180 1 14 (46.7 %) 8 (26.7 %) 
2 0 (0.0) 1 (3.3 %) 
AKI: Acute kidney injury; KDIGO: Kidney Disease 
Improving Global Outcomes 
In contrast to our study, Kim and colleagues 
found the rate of acute kidney injury was greater 
in patients who had coronary angiography 7 days 
or less before coronary artery bypass grafting. 
There was notable interaction between the timing 
of coronary angiography and the utilization of 
cardiopulmonary bypass for postoperative acute 
kidney injury [5]. 
In the study by Mehta and coworkers, they 
found the risk of post-CABG AKI was related to the 
time between cardiac catheterization and CABG, 
with the greatest frequency in those operated ≤1 
day after cardiac catheterization in spite of their 
lower risk profile. AKI was characterized as an 
increase in post-CABG serum creatinine ≥ 50% 
above baseline or the requirement for new 
dialysis. AKI occurred in 17.1% of CABG patients 
and occurred in 24.0%, 18.4%, 17.3%, 16.4%, and 
15.8% for days ≤1, 2, 3, 4, and ≥5, respectively; 
(P= 0.019) [13]. 
Jiang and colleagues in a study on 1069 
patients who underwent cardiac catheterization 
and cardiac surgery successively found that 
catheterization within 7 days of cardiac surgery 
was associated with the onset of acute kidney 
injury [14]. 
Tecson and colleagues in a study on 965 
patients who had coronary angiography followed 
by cardiac surgery found that 13.1% had contrast-
induced acute kidney injury; 13.8% had major 
adverse renal and cardiac events within 30 days 
and 26.2% within 1 year of surgery. They reported 
that patients undergoing coronary artery bypass 
graft surgery within one day of coronary 
angiography had a twofold increment in the risk 
of adverse cardiac and renal complications [15]. 
The difference between studies could be 
attributed to the different definitions of acute 
kidney injury and various patients’ population 
[16]. This study found no effect of the timing of 
coronary angiography on postoperative renal 
outcomes in patients undergoing on-pump 
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coronary artery bypass grafting, and patients can 
proceed with surgery within 7 days of the coronary 
catheterization.  
Study limitations 
The study has several limitations, including the 
small patients' number compared to the published 
series. There was a difference in the preoperative 
characteristics, and the postoperative renal 
function can be affected by several variables not 
measured in this study. Another limitation is the 
different surgical teams and perfusionists who 
performed the surgery in our cohort, which could 
have affected the outcomes. 
Conclusion 
We found no association between the timing 
of coronary angiography before on-pump 
coronary artery bypass graft surgery and 
postoperative acute kidney injury. According to 
the current study, recent cardiac catheterization 
should not be a contraindication for coronary 
artery bypass surgery; however, we recommend 
conducting larger study to confirm our findings. 
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